STOCK TITAN

Vireo Growth Inc. to Release First Quarter 2025 Results on May 9, 2025

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags

Vireo Growth has scheduled the release of its first quarter 2025 financial results for May 9, 2025, before market opening. The cannabis company, trading under symbols CSE: VREO and OTCQX: VREOF, will follow the release with an investor conference call at 8:30 a.m. ET (7:30 a.m. CT).

Stakeholders can participate in the conference call through multiple channels:

  • US/Canada Toll-Free: 1-888-672-2415
  • International Toll: 1-646-307-1963
  • Conference ID: 3718174

Additionally, interested parties can access a live audio webcast through the Events & Presentations section of Vireo's Investor Relations website or via the provided Q4 link.

Loading...
Loading translation...

Positive

  • None.

Negative

  • None.

News Market Reaction 1 Alert

+4.88% News Effect

On the day this news was published, VREOF gained 4.88%, reflecting a moderate positive market reaction.

Data tracked by StockTitan Argus on the day of publication.

MINNEAPOLIS, April 29, 2025 (GLOBE NEWSWIRE) -- Vireo Growth Inc. ("Vireo" or the "Company") (CSE: VREO; OTCQX: VREOF), today announced that it will release its financial results for its first fiscal quarter ended March 31, 2025 on Friday, May 9, 2025 before the market opens.

Vireo Growth management will host a conference call with the investment community that same day, Friday, May 9, 2025 at 8:30 a.m. ET (7:30 a.m. CT) to discuss its results. Interested parties may attend the conference call by dialing 1-888-672-2415 (Toll-Free) (US and Canada) or 1-646-307-1963 (Toll) (International) and referencing conference ID number 3718174.

A live audio webcast of this event will also be available in the Events & Presentations section of the Company’s Investor Relations website and via the following link:
https://events.q4inc.com/attendee/968886697.

About Vireo Growth Inc.

Vireo was founded as a pioneer in medical cannabis in 2014 and we are fueled by an entrepreneurial drive that sustains our ongoing commitment to serve and delight our key stakeholders, most notably our customers, our employees, our shareholders, our industry collaborators, and the communities in which we live and operate. We work every day to get better and our team prioritizes 1) empowering and supporting strong local market leaders and 2) strategic, prudent capital and human resource allocation. For more information, please visit www.vireogrowth.com.

Contact Information

Joe Duxbury
Chief Accounting Officer
investor@vireogrowth.com
(612) 314-8995


FAQ

When will Vireo Growth (VREOF) release Q1 2025 earnings?

Vireo Growth (VREOF) will release its Q1 2025 earnings on Friday, May 9, 2025, before the market opens.

How can investors join Vireo Growth's Q1 2025 earnings call?

Investors can join by dialing 1-888-672-2415 (US/Canada toll-free) or 1-646-307-1963 (International) with conference ID 3718174, on May 9, 2025, at 8:30 a.m. ET.

What time is VREOF earnings call on May 9, 2025?

The VREOF earnings call is scheduled for 8:30 a.m. ET (7:30 a.m. CT) on May 9, 2025.

Where can I watch Vireo Growth's Q1 2025 earnings webcast?

The earnings webcast will be available in the Events & Presentations section of Vireo's Investor Relations website and at events.q4inc.com/attendee/968886697.

What period does VREOF's Q1 2025 earnings report cover?

The earnings report covers Vireo Growth's first fiscal quarter, which ended March 31, 2025.
Vireo Growth Inc

OTC:VREOF

VREOF Rankings

VREOF Latest News

VREOF Latest SEC Filings

VREOF Stock Data

438.51M
762.00M
23.53%
12.66%
Drug Manufacturers - Specialty & Generic
Healthcare
Link
United States
Minneapolis